Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Consun Pharmaceutical Group Ltd. ( (HK:1681) ) just unveiled an announcement.
Consun Pharmaceutical Group Ltd. announced the successful passage of all proposed resolutions at its Annual General Meeting held on May 22, 2025. Key resolutions included the approval of the financial statements for 2024, re-election of several directors, declaration of a final dividend, and re-appointment of KPMG as auditors. The results reflect strong shareholder support and are likely to positively impact the company’s governance and financial strategies.
The most recent analyst rating on (HK:1681) stock is a Buy with a HK$7.80 price target. To see the full list of analyst forecasts on Consun Pharmaceutical Group Ltd. stock, see the HK:1681 Stock Forecast page.
More about Consun Pharmaceutical Group Ltd.
Consun Pharmaceutical Group Ltd. is a company incorporated in the Cayman Islands, focusing on the pharmaceutical industry. It is listed on the Hong Kong Stock Exchange and is involved in the production and distribution of pharmaceutical products.
Average Trading Volume: 1,858,049
Technical Sentiment Signal: Buy
Current Market Cap: HK$8.07B
Learn more about 1681 stock on TipRanks’ Stock Analysis page.